Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study

Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery dis...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 73; no. 3; pp. 291 - 301
Main Authors Williams, Michelle C., Moss, Alastair J., Dweck, Marc, Adamson, Philip D., Alam, Shirjel, Hunter, Amanda, Shah, Anoop S.V., Pawade, Tania, Weir-McCall, Jonathan R., Roditi, Giles, van Beek, Edwin J.R., Newby, David E., Nicol, Edward D.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 29.01.2019
Elsevier Limited
Elsevier Biomedical
Subjects
Online AccessGet full text
ISSN0735-1097
1558-3597
1558-3597
DOI10.1016/j.jacc.2018.10.066

Cover

Loading…
Abstract Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590) [Display omitted]
AbstractList Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.BACKGROUNDUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease.OBJECTIVESThe purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease.In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years.METHODSIn this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years.Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden.RESULTSAmong study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden.Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590).CONCLUSIONSAdverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590).
Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590) [Display omitted]
BackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.ObjectivesThe purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease.MethodsIn this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years.ResultsAmong study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden.ConclusionsAdverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590)
AbstractBackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. ObjectivesThe purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. MethodsIn this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. ResultsAmong study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. ConclusionsAdverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590)
Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590).
Author van Beek, Edwin J.R.
Moss, Alastair J.
Weir-McCall, Jonathan R.
Newby, David E.
Nicol, Edward D.
Alam, Shirjel
Hunter, Amanda
Roditi, Giles
Pawade, Tania
Adamson, Philip D.
Williams, Michelle C.
Shah, Anoop S.V.
Dweck, Marc
AuthorAffiliation d University of Cambridge School of Clinical Medicine, Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
c Christchurch Heart Institute, University of Otago, Christchurch, New Zealand
b Edinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh, United Kingdom
e Institute of Clinical Sciences, University of Glasgow, Glasgow, United Kingdom
a University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
f Royal Brompton and Harefield NHS Foundation Trust Departments of Cardiology and Radiology, London, United Kingdom
g National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, United Kingdom
AuthorAffiliation_xml – name: a University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– name: g National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, United Kingdom
– name: f Royal Brompton and Harefield NHS Foundation Trust Departments of Cardiology and Radiology, London, United Kingdom
– name: d University of Cambridge School of Clinical Medicine, Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
– name: c Christchurch Heart Institute, University of Otago, Christchurch, New Zealand
– name: b Edinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh, United Kingdom
– name: e Institute of Clinical Sciences, University of Glasgow, Glasgow, United Kingdom
Author_xml – sequence: 1
  givenname: Michelle C.
  surname: Williams
  fullname: Williams, Michelle C.
  email: michelle.williams@ed.ac.uk
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 2
  givenname: Alastair J.
  surname: Moss
  fullname: Moss, Alastair J.
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 3
  givenname: Marc
  surname: Dweck
  fullname: Dweck, Marc
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 4
  givenname: Philip D.
  surname: Adamson
  fullname: Adamson, Philip D.
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 5
  givenname: Shirjel
  surname: Alam
  fullname: Alam, Shirjel
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 6
  givenname: Amanda
  surname: Hunter
  fullname: Hunter, Amanda
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 7
  givenname: Anoop S.V.
  surname: Shah
  fullname: Shah, Anoop S.V.
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 8
  givenname: Tania
  surname: Pawade
  fullname: Pawade, Tania
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 9
  givenname: Jonathan R.
  surname: Weir-McCall
  fullname: Weir-McCall, Jonathan R.
  organization: University of Cambridge School of Clinical Medicine, Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
– sequence: 10
  givenname: Giles
  surname: Roditi
  fullname: Roditi, Giles
  organization: Institute of Clinical Sciences, University of Glasgow, Glasgow, United Kingdom
– sequence: 11
  givenname: Edwin J.R.
  surname: van Beek
  fullname: van Beek, Edwin J.R.
  organization: Edinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh, United Kingdom
– sequence: 12
  givenname: David E.
  surname: Newby
  fullname: Newby, David E.
  organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
– sequence: 13
  givenname: Edward D.
  surname: Nicol
  fullname: Nicol, Edward D.
  organization: Royal Brompton and Harefield NHS Foundation Trust Departments of Cardiology and Radiology, London, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30678759$$D View this record in MEDLINE/PubMed
BookMark eNqFUl2LEzEUDbLidlf_gA8y4IsvU_PRSTIiC0PZdYWFiq34GNPMHZs6newmmUL_jb9lf5kZuhYtuD5duDnn5J577hk66VwHCL0keEww4W_X47U2Zkwxkakxxpw_QSNSFDJnRSlO0AgLVuQEl-IUnYWwxhhzScpn6JRhLqQoyhH6NnXeddrvsspHSOVTq-96yKYr7bVJHRuiNSGrQnDG6gh19tXGVVbVW_ABslkfjdtAyGx3_zOuIJtPZ4v8-rL6vMjmsa93z9HTRrcBXjzUc_Tl6nIxvc5vZh8-Tqub3BSyjLkGUTOOtWmkwZxKzWFSaIonmDDDyZIxCkZg3HAQQjR6qRvGQEojxVLzyZKdo4u97m2_3EBtoItet-rW201yp5y26u-Xzq7Ud7dVnE2oLFkSePMg4F3aQIhqY4OBttUduD4oSkQ54SWTJEFfH0HXrvddspdQvKSUSzwIvvpzosMov5efAHQPMN6F4KE5QAhWQ8JqrYaE1ZDw0EsJJ5I8IhkbdbRucGXbx6nv91RIOWwteBWMhc5AbT2YqGpnH6dfHNFNaztrdPsDdhAOKyAqUIXVfLi-4fiIZCUleBB492-B__3-Czhj6m4
CitedBy_id crossref_primary_10_1002_ccd_31307
crossref_primary_10_4070_kcj_2022_0265
crossref_primary_10_1093_eurheartj_ehz962
crossref_primary_10_3390_jcm12134550
crossref_primary_10_1038_s44161_022_00042_8
crossref_primary_10_1016_j_jacasi_2021_05_003
crossref_primary_10_1016_j_jcct_2019_07_002
crossref_primary_10_1136_heartjnl_2021_320147
crossref_primary_10_1016_j_jcct_2019_07_005
crossref_primary_10_1016_j_atherosclerosis_2022_11_008
crossref_primary_10_5551_jat_63580
crossref_primary_10_1136_heartjnl_2021_320265
crossref_primary_10_1016_j_jcct_2022_07_006
crossref_primary_10_1016_j_jcmg_2022_03_016
crossref_primary_10_1093_ehjci_jeaa051
crossref_primary_10_1093_ehjci_jeaa173
crossref_primary_10_1080_14779072_2021_1915132
crossref_primary_10_1136_openhrt_2024_002755
crossref_primary_10_2174_011573403X321064240715061250
crossref_primary_10_3390_diagnostics12071660
crossref_primary_10_1001_jamacardio_2021_3055
crossref_primary_10_1016_j_jcct_2019_07_010
crossref_primary_10_1093_eurheartj_ehac061
crossref_primary_10_1007_s10554_020_02052_8
crossref_primary_10_1016_j_hlc_2023_06_703
crossref_primary_10_1016_j_rcl_2023_05_004
crossref_primary_10_1148_ryct_240142
crossref_primary_10_1007_s10554_020_01954_x
crossref_primary_10_1016_j_jcct_2021_05_004
crossref_primary_10_1016_j_crad_2019_08_023
crossref_primary_10_1016_j_jcmg_2019_11_006
crossref_primary_10_1016_j_jcmg_2023_05_011
crossref_primary_10_1093_ehjci_jeab135
crossref_primary_10_1097_MCA_0000000000001225
crossref_primary_10_1016_j_medp_2023_100001
crossref_primary_10_1093_ehjci_jeaa048
crossref_primary_10_1111_echo_70100
crossref_primary_10_1016_j_jcmg_2021_09_021
crossref_primary_10_1186_s12933_019_0878_1
crossref_primary_10_1007_s00330_024_10739_y
crossref_primary_10_1016_j_jcct_2020_11_002
crossref_primary_10_1148_radiol_230524
crossref_primary_10_1016_j_jcct_2020_11_001
crossref_primary_10_1007_s00508_021_01970_4
crossref_primary_10_1016_j_jcmg_2021_02_026
crossref_primary_10_1002_clc_23686
crossref_primary_10_1016_j_jcmg_2019_03_003
crossref_primary_10_1161_CIRCULATIONAHA_123_065657
crossref_primary_10_1093_ehjci_jeac044
crossref_primary_10_1007_s10554_023_02962_3
crossref_primary_10_1016_j_clinimag_2023_06_009
crossref_primary_10_1016_j_atherosclerosis_2022_04_011
crossref_primary_10_1016_j_jacc_2020_11_005
crossref_primary_10_1016_j_atherosclerosis_2021_08_032
crossref_primary_10_1093_cvr_cvz173
crossref_primary_10_1016_j_atherosclerosis_2020_06_021
crossref_primary_10_1007_s12350_019_01832_7
crossref_primary_10_1016_j_jcct_2019_08_009
crossref_primary_10_3390_diagnostics13233574
crossref_primary_10_3389_fcvm_2021_691665
crossref_primary_10_31083_j_rcm2512442
crossref_primary_10_1007_s12410_022_09564_y
crossref_primary_10_1016_j_jcct_2024_02_003
crossref_primary_10_1016_j_athplu_2021_07_021
crossref_primary_10_1016_j_atherosclerosis_2025_119105
crossref_primary_10_1186_s13073_024_01313_8
crossref_primary_10_1161_ATVBAHA_124_321504
crossref_primary_10_1016_j_jacc_2020_01_002
crossref_primary_10_1016_j_endinu_2022_03_004
crossref_primary_10_1016_j_jcct_2023_10_005
crossref_primary_10_1016_j_ejrad_2023_111282
crossref_primary_10_1016_j_jacc_2020_12_050
crossref_primary_10_1007_s00330_022_08594_w
crossref_primary_10_1038_s41598_025_87118_0
crossref_primary_10_15420_usc_2021_22
crossref_primary_10_1016_j_jcmg_2019_03_033
crossref_primary_10_15420_usc_2021_30
crossref_primary_10_1007_s00395_024_01033_5
crossref_primary_10_1093_eurheartj_ehae471
crossref_primary_10_1007_s11547_020_01277_w
crossref_primary_10_1016_j_jcct_2020_06_198
crossref_primary_10_1016_j_jcmg_2024_06_012
crossref_primary_10_1016_j_jacc_2024_03_386
crossref_primary_10_1093_ehjci_jeab292
crossref_primary_10_1093_ehjci_jeab293
crossref_primary_10_4250_jcvi_2021_0016
crossref_primary_10_1093_ehjci_jeaa081
crossref_primary_10_3389_fcvm_2022_997649
crossref_primary_10_1038_s41569_024_01110_1
crossref_primary_10_1007_s12471_024_01902_7
crossref_primary_10_3390_jcm9123925
crossref_primary_10_1016_j_jcct_2022_07_002
crossref_primary_10_1177_00033197231158937
crossref_primary_10_1016_j_actbio_2025_01_035
crossref_primary_10_1093_ehjci_jeae314
crossref_primary_10_1093_ehjci_jeab287
crossref_primary_10_1186_s12968_022_00858_0
crossref_primary_10_1148_radiol_222827
crossref_primary_10_36660_abc_20240608
crossref_primary_10_1016_j_rcl_2023_12_017
crossref_primary_10_3390_jcdd9100350
crossref_primary_10_1161_CIRCIMAGING_122_014611
crossref_primary_10_1093_ehjci_jeaa192
crossref_primary_10_1007_s11739_024_03672_x
crossref_primary_10_3348_kjr_2022_0115
crossref_primary_10_1016_j_jcmg_2020_01_013
crossref_primary_10_2459_JCM_0000000000001235
crossref_primary_10_3390_ijms21124538
crossref_primary_10_3389_fcvm_2022_836473
crossref_primary_10_1093_eurjpc_zwab202
crossref_primary_10_1007_s12350_022_02908_7
crossref_primary_10_1177_23971983241264090
crossref_primary_10_1161_CIRCINTERVENTIONS_119_008355
crossref_primary_10_5694_mja2_52018
crossref_primary_10_1177_17539447241303399
crossref_primary_10_1016_j_amjcard_2020_11_006
crossref_primary_10_1161_CIRCIMAGING_120_011438
crossref_primary_10_1016_j_jcct_2021_07_001
crossref_primary_10_3390_diagnostics13020307
crossref_primary_10_1007_s11926_019_0875_0
crossref_primary_10_1007_s00259_019_04667_z
crossref_primary_10_1016_j_jcct_2022_09_003
crossref_primary_10_1161_CIRCIMAGING_123_016152
crossref_primary_10_1016_j_tem_2019_06_001
crossref_primary_10_3390_life13020507
crossref_primary_10_1371_journal_pone_0304137
crossref_primary_10_1093_ehjci_jeaa201
crossref_primary_10_1111_eci_14188
crossref_primary_10_3390_life13030696
crossref_primary_10_3390_jcdd11080245
crossref_primary_10_2337_dc21_1663
crossref_primary_10_1016_j_jcct_2019_06_017
crossref_primary_10_1093_ehjci_jeaa208
crossref_primary_10_3389_fcvm_2023_1143119
crossref_primary_10_17816_DD71633
crossref_primary_10_1148_radiol_2021204704
crossref_primary_10_1016_j_jcct_2024_05_232
crossref_primary_10_1148_ryct_220183
crossref_primary_10_1007_s11886_022_01825_y
crossref_primary_10_1016_j_jcct_2019_10_006
crossref_primary_10_4244_EIJ_E_24_00004
crossref_primary_10_1016_j_jcmg_2021_10_009
crossref_primary_10_1148_ryct_230090
crossref_primary_10_1259_bjr_20190921
crossref_primary_10_1016_j_jacc_2020_06_076
crossref_primary_10_1148_ryct_210260
crossref_primary_10_1016_j_jacasi_2024_04_001
crossref_primary_10_1016_j_jacc_2021_06_019
crossref_primary_10_1093_eurheartj_suab072
crossref_primary_10_1016_j_endien_2022_11_009
crossref_primary_10_1161_CIRCIMAGING_123_016057
crossref_primary_10_1007_s00330_025_11353_2
crossref_primary_10_1016_j_jjcc_2021_12_006
crossref_primary_10_2459_JCM_0000000000001433
crossref_primary_10_1161_CIRCULATIONAHA_119_044720
crossref_primary_10_1093_ehjci_jeaa022
crossref_primary_10_1007_s00330_021_08429_0
crossref_primary_10_3390_jcm10030521
crossref_primary_10_31083_j_rcm2501027
crossref_primary_10_1016_j_jcmg_2022_04_024
crossref_primary_10_1038_s41598_022_08425_4
crossref_primary_10_1001_jamacardio_2021_5705
crossref_primary_10_1016_j_jcct_2024_12_083
crossref_primary_10_1093_ehjci_jeaa130
crossref_primary_10_7326_M22_3027
crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106719
crossref_primary_10_1007_s11883_022_01029_3
crossref_primary_10_1016_j_acvd_2022_07_001
crossref_primary_10_1016_j_ejrad_2022_110601
crossref_primary_10_1148_ryct_220188
crossref_primary_10_1093_ehjcr_ytab095
crossref_primary_10_3892_etm_2019_8371
crossref_primary_10_7326_L23_0262
crossref_primary_10_3389_fcvm_2021_716832
crossref_primary_10_1080_21548331_2022_2030630
crossref_primary_10_1111_1754_9485_13817
crossref_primary_10_1007_s12350_019_01901_x
crossref_primary_10_1177_17539447241249650
crossref_primary_10_1016_j_jcmg_2021_03_004
crossref_primary_10_1016_j_jcct_2024_10_011
crossref_primary_10_1177_00033197241233634
crossref_primary_10_1016_j_jcct_2024_10_013
crossref_primary_10_1016_j_jcmg_2022_05_014
crossref_primary_10_1148_ryct_210171
crossref_primary_10_4244_EIJ_E_22_00051
crossref_primary_10_1007_s00059_023_05207_0
crossref_primary_10_1016_j_pcad_2022_10_013
crossref_primary_10_3390_jcm13061556
crossref_primary_10_4070_kcj_2019_0315
crossref_primary_10_1016_j_jcct_2019_05_010
crossref_primary_10_1007_s10554_023_02918_7
crossref_primary_10_1016_j_jacc_2020_05_078
crossref_primary_10_1097_MD_0000000000028801
crossref_primary_10_1148_radiol_213271
crossref_primary_10_1186_s12933_022_01615_4
crossref_primary_10_1093_eurheartj_ehz592
crossref_primary_10_1161_CIRCIMAGING_123_016143
crossref_primary_10_31083_j_rcm2408245
crossref_primary_10_3390_jpm15030100
crossref_primary_10_1055_a_2499_3122
crossref_primary_10_1007_s10554_021_02429_3
crossref_primary_10_1016_j_ejrad_2021_109551
crossref_primary_10_1016_j_jid_2022_05_1085
crossref_primary_10_1093_eurheartj_ehae177
crossref_primary_10_1148_radiol_240876
crossref_primary_10_36660_abc_20240608i
crossref_primary_10_1016_j_jcct_2024_04_009
crossref_primary_10_1161_CIRCULATIONAHA_122_060308
crossref_primary_10_1007_s12350_020_02086_4
crossref_primary_10_1016_j_ancard_2022_10_002
crossref_primary_10_54912_jci_2022_0025
crossref_primary_10_1016_j_jcmg_2019_09_011
crossref_primary_10_1016_j_jcmg_2019_09_012
crossref_primary_10_1016_j_jcmg_2023_08_006
crossref_primary_10_17816_mechnikov629024
crossref_primary_10_3390_app13010241
crossref_primary_10_1016_j_jcmg_2023_08_005
crossref_primary_10_1186_s12968_021_00758_9
crossref_primary_10_1016_j_jcmg_2023_08_002
crossref_primary_10_1161_CIRCIMAGING_121_012514
crossref_primary_10_1016_j_atherosclerosis_2020_03_008
crossref_primary_10_1259_bjr_20190880
crossref_primary_10_1161_CIRCIMAGING_123_015236
crossref_primary_10_1016_j_atherosclerosis_2020_03_001
crossref_primary_10_3390_diagnostics13122074
crossref_primary_10_1016_j_ejrad_2022_110269
crossref_primary_10_1007_s10554_020_01926_1
crossref_primary_10_3390_jcm12030903
crossref_primary_10_1007_s10554_022_02785_8
crossref_primary_10_1002_lt_25869
crossref_primary_10_1016_j_jcmg_2023_08_018
crossref_primary_10_1038_s41598_023_38675_9
crossref_primary_10_1093_eurheartj_ehab405
crossref_primary_10_1007_s11886_023_01982_8
crossref_primary_10_3389_fcvm_2023_1235144
crossref_primary_10_1136_heartjnl_2019_315607
crossref_primary_10_1259_bjr_20190740
crossref_primary_10_1007_s00259_024_07055_4
crossref_primary_10_1007_s00330_021_07726_y
crossref_primary_10_1016_j_atherosclerosis_2020_03_019
crossref_primary_10_1007_s00330_022_08894_1
crossref_primary_10_1016_j_ajpc_2021_100294
crossref_primary_10_1016_j_jcmg_2020_11_007
crossref_primary_10_1016_j_jcmg_2022_06_001
crossref_primary_10_1007_s10140_021_01973_8
crossref_primary_10_3390_jcm11030477
crossref_primary_10_1016_j_clinthera_2023_09_019
crossref_primary_10_1038_s41467_021_26146_6
crossref_primary_10_1007_s11886_022_01831_0
crossref_primary_10_1016_j_jcmg_2023_08_021
crossref_primary_10_1016_j_pcad_2023_09_001
crossref_primary_10_1007_s11883_020_00879_z
crossref_primary_10_1016_j_jacadv_2022_100078
crossref_primary_10_1016_j_jacc_2022_03_381
crossref_primary_10_3390_jcm10040625
crossref_primary_10_1097_RTI_0000000000000711
crossref_primary_10_1186_s12880_024_01325_1
crossref_primary_10_1259_bjr_20220346
crossref_primary_10_1259_bjr_20190763
crossref_primary_10_1007_s00330_023_09888_3
crossref_primary_10_1016_j_jcct_2021_02_002
crossref_primary_10_1001_jamacardio_2023_4390
crossref_primary_10_2478_jim_2021_0007
crossref_primary_10_2478_jim_2021_0006
crossref_primary_10_2478_jim_2021_0005
crossref_primary_10_2478_jim_2021_0008
crossref_primary_10_1055_a_2307_5162
crossref_primary_10_1016_j_jcmg_2024_02_001
crossref_primary_10_1093_ehjci_jez031
crossref_primary_10_3390_life13051086
crossref_primary_10_1016_j_metabol_2022_155370
crossref_primary_10_1016_j_jphs_2019_12_005
crossref_primary_10_1016_j_jacc_2021_10_044
crossref_primary_10_1007_s11604_024_01543_1
crossref_primary_10_3389_fcvm_2021_775115
crossref_primary_10_1136_heartjnl_2020_318269
crossref_primary_10_1148_radiol_223342
crossref_primary_10_7759_cureus_78365
crossref_primary_10_1016_j_jcct_2024_06_009
crossref_primary_10_1038_s41569_023_00900_3
crossref_primary_10_1016_j_atherosclerosis_2023_02_005
crossref_primary_10_1016_j_jcmg_2020_04_027
crossref_primary_10_1161_JAHA_121_022697
crossref_primary_10_36660_abc_20230105
crossref_primary_10_1161_CIRCIMAGING_120_011199
crossref_primary_10_1016_j_jacc_2019_03_465
crossref_primary_10_1007_s00330_023_10439_z
crossref_primary_10_1016_j_jcct_2020_08_007
crossref_primary_10_1148_ryct_2021200563
crossref_primary_10_1097_HCO_0000000000001077
crossref_primary_10_1016_j_amjmed_2021_03_014
crossref_primary_10_1161_JAHA_123_033639
crossref_primary_10_1016_j_jcct_2022_02_005
crossref_primary_10_1016_j_jcmg_2021_12_015
crossref_primary_10_1007_s11936_020_00818_w
crossref_primary_10_1016_j_jcct_2022_02_002
crossref_primary_10_1016_j_hlc_2022_12_003
crossref_primary_10_1016_j_jcmg_2022_07_002
crossref_primary_10_1093_ehjci_jez253
crossref_primary_10_1016_j_atherosclerosis_2022_01_020
crossref_primary_10_3390_jcm12247615
crossref_primary_10_1016_j_jcmg_2020_03_002
crossref_primary_10_1097_MCA_0000000000000851
crossref_primary_10_1016_j_jcmg_2023_10_002
crossref_primary_10_4274_dir_2023_232196
crossref_primary_10_1016_j_atherosclerosis_2024_117579
crossref_primary_10_1016_j_jcmg_2019_07_011
crossref_primary_10_3390_diagnostics13010125
crossref_primary_10_1016_j_jcct_2019_03_007
crossref_primary_10_15836_ccar2020_193
crossref_primary_10_1016_j_jcin_2023_03_041
crossref_primary_10_1016_j_jjcc_2024_05_009
crossref_primary_10_1155_2021_5597467
crossref_primary_10_1093_ehjqcco_qcaa006
crossref_primary_10_1016_j_clinimag_2022_08_005
crossref_primary_10_1016_j_jcmg_2021_11_007
crossref_primary_10_1007_s00330_020_07037_8
crossref_primary_10_1016_j_atherosclerosis_2024_117449
crossref_primary_10_1148_radiol_2020200605
crossref_primary_10_1007_s00117_024_01287_z
crossref_primary_10_1007_s11883_024_01205_7
crossref_primary_10_1093_ehjci_jeae029
crossref_primary_10_1186_s12933_024_02527_1
crossref_primary_10_1186_s41747_023_00410_4
crossref_primary_10_1007_s10554_020_01802_y
crossref_primary_10_1007_s11883_023_01178_z
crossref_primary_10_2478_jce_2023_0015
crossref_primary_10_1161_ATVBAHA_119_312899
crossref_primary_10_3390_diagnostics14151671
crossref_primary_10_1259_bjr_20180309
crossref_primary_10_3390_diagnostics12061446
crossref_primary_10_1007_s10554_024_03149_0
crossref_primary_10_1038_s44161_024_00420_4
crossref_primary_10_1097_MCA_0000000000001292
crossref_primary_10_1016_j_jcmg_2020_05_040
crossref_primary_10_3390_tomography9050140
crossref_primary_10_1016_j_jcmg_2019_05_009
crossref_primary_10_1259_bjr_20220885
crossref_primary_10_1007_s00330_023_10223_z
crossref_primary_10_33590_emjradiol_10308328
crossref_primary_10_1111_echo_70032
crossref_primary_10_1016_j_atherosclerosis_2024_117580
crossref_primary_10_1136_heartjnl_2022_321360
crossref_primary_10_1136_bcr_2019_232104
crossref_primary_10_4274_jmsr_galenos_2023_2023_9_1
crossref_primary_10_1016_j_jcct_2021_03_010
crossref_primary_10_1016_j_jcct_2019_09_009
crossref_primary_10_3390_jcdd9100329
crossref_primary_10_3389_fcvm_2021_743538
crossref_primary_10_1148_radiol_221784
crossref_primary_10_1038_s41598_022_19546_1
crossref_primary_10_3389_fcvm_2025_1543816
crossref_primary_10_1097_MCA_0000000000001190
crossref_primary_10_1002_jcu_23680
crossref_primary_10_1016_j_jacc_2023_09_817
crossref_primary_10_1016_j_jacasi_2024_09_009
crossref_primary_10_1016_j_jcct_2024_01_012
crossref_primary_10_1016_j_jcmg_2018_11_037
crossref_primary_10_1001_jamacardio_2020_1567
crossref_primary_10_1093_bjr_tqae216
crossref_primary_10_1016_j_jcmg_2021_06_001
crossref_primary_10_1093_eurheartj_ehac597
crossref_primary_10_23736_S0026_4806_20_06759_2
crossref_primary_10_1007_s12350_019_02004_3
crossref_primary_10_1136_bmjopen_2021_058304
crossref_primary_10_1136_heartjnl_2024_324858
crossref_primary_10_3348_jksr_2021_0170
crossref_primary_10_1111_bph_14868
crossref_primary_10_1148_radiol_230124
crossref_primary_10_1161_JAHA_123_029950
crossref_primary_10_1016_j_tcm_2021_08_014
crossref_primary_10_1016_j_jcmg_2020_06_034
crossref_primary_10_1111_bph_14896
crossref_primary_10_1148_ryct_230313
crossref_primary_10_3390_healthcare12050520
crossref_primary_10_1093_ehjci_jez089
crossref_primary_10_1016_j_atherosclerosis_2024_118593
crossref_primary_10_1016_j_atherosclerosis_2019_06_914
crossref_primary_10_1093_eurheartj_ehz930
crossref_primary_10_1161_CIRCULATIONAHA_121_057789
crossref_primary_10_1016_j_tcm_2021_08_009
crossref_primary_10_1556_1647_2021_00033
crossref_primary_10_1148_radiol_2020192791
crossref_primary_10_1016_j_ajpc_2022_100432
crossref_primary_10_1007_s00398_024_00663_0
crossref_primary_10_1016_j_acra_2022_09_004
crossref_primary_10_1016_j_jacadv_2024_100861
crossref_primary_10_1097_CD9_0000000000000126
crossref_primary_10_1016_j_crad_2019_06_034
crossref_primary_10_1002_clc_23989
crossref_primary_10_3390_jcm11195663
crossref_primary_10_1007_s00330_023_09721_x
crossref_primary_10_1161_CIRCIMAGING_124_017066
crossref_primary_10_1097_MOL_0000000000000645
crossref_primary_10_1007_s11845_024_03745_y
crossref_primary_10_1097_MD_0000000000039595
crossref_primary_10_1371_journal_pone_0240539
crossref_primary_10_1016_j_jcct_2021_10_010
crossref_primary_10_1186_s12883_024_03788_9
crossref_primary_10_1097_LVT_0000000000000215
crossref_primary_10_1093_bjr_tqae246
crossref_primary_10_1093_ehjci_jead072
crossref_primary_10_1161_CIRCULATIONAHA_120_049840
crossref_primary_10_1016_j_jacr_2022_09_012
crossref_primary_10_1148_ryct_2019190069
crossref_primary_10_1148_radiol_221693
crossref_primary_10_1161_ATVBAHA_123_320065
crossref_primary_10_1016_j_jcct_2025_01_007
crossref_primary_10_4244_EIJ_D_23_00487
crossref_primary_10_1016_j_jacc_2018_11_017
crossref_primary_10_1148_ryct_240242
crossref_primary_10_1055_a_1395_7905
Cites_doi 10.1136/hrt.2006.108167
10.1016/j.jcct.2017.11.014
10.1097/RLI.0b013e31828fdf9f
10.1161/CIRCIMAGING.116.004896
10.1136/heart.83.3.361
10.1001/jamainternmed.2016.7585
10.1016/j.jcct.2017.09.001
10.1016/j.jacc.2018.02.079
10.1136/hrt.82.3.265
10.1016/0735-1097(90)90282-T
10.1016/0735-1097(93)90050-B
10.1034/j.1600-0854.2003.8042.x
10.1093/ehjci/jev325
10.1161/CIRCULATIONAHA.116.024360
10.1016/j.jacc.2015.05.069
10.1016/S0140-6736(15)60291-4
10.1016/j.jacc.2016.02.026
10.1186/1745-6215-13-184
10.1136/openhrt-2014-000234
10.1056/NEJMoa1805971
10.1161/01.CIR.51.4.5
10.1016/j.jacc.2007.03.044
10.1016/j.jacc.2009.02.068
10.1016/j.jacc.2012.10.054
10.1016/j.jcmg.2012.03.019
10.1161/CIRCULATIONAHA.117.030578
10.1016/0735-1097(90)90298-4
10.1007/s12350-014-9865-9
10.1001/jama.2014.14681
10.1161/CIRCULATIONAHA.117.031178
10.1001/jamacardio.2017.4973
10.1161/CIRCULATIONAHA.105.580696
10.1016/j.jcmg.2018.04.015
10.1253/circj.71.363
ContentType Journal Article
Copyright 2019 The Authors
The Authors
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Jan 29, 2019
2019 The Authors 2019
Copyright_xml – notice: 2019 The Authors
– notice: The Authors
– notice: Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Jan 29, 2019
– notice: 2019 The Authors 2019
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
5PM
DOI 10.1016/j.jacc.2018.10.066
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

AIDS and Cancer Research Abstracts


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
EndPage 301
ExternalDocumentID PMC6342893
30678759
10_1016_j_jacc_2018_10_066
S0735109718392106
1_s2_0_S0735109718392106
Genre Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: British Heart Foundation
  grantid: FS/14/78/31020
– fundername: Chief Scientist Office
  grantid: CZH/4/588
– fundername: Chief Scientist Office
  grantid: PCL/17/04
– fundername: British Heart Foundation
  grantid: RE/13/3/30183
– fundername: British Heart Foundation
  grantid: FS/11/014
– fundername: British Heart Foundation
  grantid: FS/16/19/31982
– fundername: British Heart Foundation
  grantid: CH/09/002
– fundername: Medical Research Council
  grantid: G0701127
– fundername: Wellcome Trust
  grantid: WT103782AIA
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
1~5
2WC
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
AABNK
AABVL
AAEDT
AAEDW
AAIKJ
AALRI
AAOAW
AAQFI
AAQQT
AAXUO
ABBQC
ABFNM
ABFRF
ABLJU
ABMAC
ABMZM
ABOCM
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFPUW
AFRAH
AFRHN
AFTJW
AGCQF
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BLXMC
CS3
DIK
DU5
E3Z
EBS
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FNPLU
G-Q
GBLVA
GX1
HVGLF
IHE
IXB
J1W
K-O
KQ8
L7B
MO0
N9A
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SSZ
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
YYM
YZZ
Z5R
.55
.GJ
0SF
1CY
29L
3O-
3V.
6I.
7RV
AACTN
AAFTH
AAKUH
AAQXK
AAYOK
ABVKL
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
AFCTW
AFETI
AFFNX
AGHFR
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
BENPR
BPHCQ
FGOYB
H13
HX~
HZ~
J5H
N4W
NCXOZ
PROAC
QTD
R2-
RIG
SEW
T5K
X7M
XPP
YYP
ZGI
ZXP
AAIAV
ABJNI
EFLBG
LCYCR
NAHTW
ZA5
AAYWO
AAYXX
AGQPQ
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-c589t-ae7d360acf8c0628a6e45a204013c61b332ec700f6e777fabaf33e88c87ba64b3
IEDL.DBID IXB
ISSN 0735-1097
1558-3597
IngestDate Thu Aug 21 13:44:34 EDT 2025
Fri Jul 11 00:14:50 EDT 2025
Fri Jul 25 09:25:11 EDT 2025
Mon Jul 21 05:36:05 EDT 2025
Tue Jul 01 04:22:36 EDT 2025
Thu Apr 24 23:05:29 EDT 2025
Fri Feb 23 02:45:22 EST 2024
Sun Feb 23 10:18:58 EST 2025
Tue Aug 26 19:31:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords computed tomography
coronary artery disease
CT
CTA
AU
CI
HR
IQR
atherosclerotic plaque
coronary angiography
computed tomography angiography
interquartile range
Agatston units
hazard ratio
confidence interval
Language English
License This is an open access article under the CC BY license.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c589t-ae7d360acf8c0628a6e45a204013c61b332ec700f6e777fabaf33e88c87ba64b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0735109718392106
PMID 30678759
PQID 2169226803
PQPubID 2031078
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6342893
proquest_miscellaneous_2179469381
proquest_journals_2169226803
pubmed_primary_30678759
crossref_primary_10_1016_j_jacc_2018_10_066
crossref_citationtrail_10_1016_j_jacc_2018_10_066
elsevier_sciencedirect_doi_10_1016_j_jacc_2018_10_066
elsevier_clinicalkeyesjournals_1_s2_0_S0735109718392106
elsevier_clinicalkey_doi_10_1016_j_jacc_2018_10_066
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-01-29
PublicationDateYYYYMMDD 2019-01-29
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-29
  day: 29
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2019
Publisher Elsevier Inc
Elsevier Limited
Elsevier Biomedical
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
– name: Elsevier Biomedical
References Narula, Nakano, Virmani (bib19) 2013; 61
Naoum, Berman, Ahmadi (bib34) 2017; 10
Van Lierde, De Geest, Verstraete, Van de Werf (bib24) 1990; 16
Motoyama, Sarai, Harigaya (bib3) 2009; 54
Lee, Chang, Sung (bib32) 2018; 11
Agatston, Janowitz, Hildner, Zusmer, Viamonte, Detrano (bib11) 1990; 15
Schlett, Maurovich-Horvat, Ferencik (bib18) 2013; 48
Chang, Lin, Lee (bib25) 2018; 71
Davies (bib22) 2000; 83
Joseph, Ackerman, Talley, Johnstone, Kupersmith (bib33) 1993; 22
Ferencik, Mayrhofer, Bittner (bib21) 2018; 3
Newby (bib30) 2017; 136
Conte, Annoni, Pontone (bib5) 2017; 18
Austen, Edwards, Frye (bib12) 1975; 51
Mann, Davies (bib26) 1999; 82
Hoffmann, Ferencik, Udelson (bib36) 2017; 135
Maddox, Stanislawski, Grunwald (bib23) 2014; 312
Motoyama, Ito, Sarai (bib2) 2015; 66
Takamura, Fujimoto, Kondo (bib29) 2017
Motoyama, Kondo, Sarai (bib17) 2007; 50
Obaid, Calvert, Brown (bib20) 2017; 11
(bib6) 2018; 379
(bib7) 2015; 385
Maroules, Hamilton-Craig, Branch (bib16) 2018; 12
Thomsen, Abdulla (bib4) 2016; 17
Motoyama, Kondo, Anno (bib14) 2007; 71
Virmani, Burke, Kolodgie, Farb (bib1) 2003; 16
Shah, Bellam, Leipsic (bib27) 2014; 21
Williams, Hunter, Shah (bib8) 2016; 67
Redberg, Katz (bib35) 2017; 177
Newby, Williams, Flapan (bib9) 2012; 13
Budoff, Mayrhofer, Ferencik (bib31) 2017; 136
Williams, Golay, Hunter (bib13) 2015; 2
McClelland, Chung, Detrano, Post, Kronmal (bib28) 2006; 113
Maurovich-Horvat, Schlett, Alkadhi (bib15) 2012; 5
Woodward, Brindle, Tunstall-Pedoe (bib10) 2007; 93
Motoyama (10.1016/j.jacc.2018.10.066_bib3) 2009; 54
Maddox (10.1016/j.jacc.2018.10.066_bib23) 2014; 312
Motoyama (10.1016/j.jacc.2018.10.066_bib17) 2007; 50
Hoffmann (10.1016/j.jacc.2018.10.066_bib36) 2017; 135
Conte (10.1016/j.jacc.2018.10.066_bib5) 2017; 18
Agatston (10.1016/j.jacc.2018.10.066_bib11) 1990; 15
Austen (10.1016/j.jacc.2018.10.066_bib12) 1975; 51
Woodward (10.1016/j.jacc.2018.10.066_bib10) 2007; 93
Schlett (10.1016/j.jacc.2018.10.066_bib18) 2013; 48
McClelland (10.1016/j.jacc.2018.10.066_bib28) 2006; 113
Virmani (10.1016/j.jacc.2018.10.066_bib1) 2003; 16
Thomsen (10.1016/j.jacc.2018.10.066_bib4) 2016; 17
Williams (10.1016/j.jacc.2018.10.066_bib8) 2016; 67
Motoyama (10.1016/j.jacc.2018.10.066_bib2) 2015; 66
Joseph (10.1016/j.jacc.2018.10.066_bib33) 1993; 22
Chang (10.1016/j.jacc.2018.10.066_bib25) 2018; 71
Obaid (10.1016/j.jacc.2018.10.066_bib20) 2017; 11
Ferencik (10.1016/j.jacc.2018.10.066_bib21) 2018; 3
Maurovich-Horvat (10.1016/j.jacc.2018.10.066_bib15) 2012; 5
Williams (10.1016/j.jacc.2018.10.066_bib13) 2015; 2
Shah (10.1016/j.jacc.2018.10.066_bib27) 2014; 21
Takamura (10.1016/j.jacc.2018.10.066_bib29) 2017
Budoff (10.1016/j.jacc.2018.10.066_bib31) 2017; 136
Redberg (10.1016/j.jacc.2018.10.066_bib35) 2017; 177
Motoyama (10.1016/j.jacc.2018.10.066_bib14) 2007; 71
(10.1016/j.jacc.2018.10.066_bib7) 2015; 385
Narula (10.1016/j.jacc.2018.10.066_bib19) 2013; 61
Davies (10.1016/j.jacc.2018.10.066_bib22) 2000; 83
Mann (10.1016/j.jacc.2018.10.066_bib26) 1999; 82
Naoum (10.1016/j.jacc.2018.10.066_bib34) 2017; 10
(10.1016/j.jacc.2018.10.066_bib6) 2018; 379
Van Lierde (10.1016/j.jacc.2018.10.066_bib24) 1990; 16
Lee (10.1016/j.jacc.2018.10.066_bib32) 2018; 11
Newby (10.1016/j.jacc.2018.10.066_bib9) 2012; 13
Maroules (10.1016/j.jacc.2018.10.066_bib16) 2018; 12
Newby (10.1016/j.jacc.2018.10.066_bib30) 2017; 136
30678760 - J Am Coll Cardiol. 2019 Jan 29;73(3):302-304. doi: 10.1016/j.jacc.2018.11.017.
References_xml – volume: 82
  start-page: 265
  year: 1999
  end-page: 268
  ident: bib26
  article-title: Mechanisms of progression in native coronary artery disease: role of healed plaque disruption
  publication-title: Heart
– volume: 11
  start-page: 1475
  year: 2018
  end-page: 1484
  ident: bib32
  article-title: Effects of statins on coronary atherosclerotic plaques: The PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) Study
  publication-title: J Am Coll Cardiol Img
– volume: 15
  start-page: 827
  year: 1990
  end-page: 832
  ident: bib11
  article-title: Quantification of coronary artery calcium using ultrafast computed tomography
  publication-title: J Am Coll Cardiol
– volume: 67
  start-page: 1759
  year: 2016
  end-page: 1768
  ident: bib8
  article-title: Use of coronary computed tomographic angiography to guide management of patients with coronary disease
  publication-title: J Am Coll Cardiol
– volume: 66
  start-page: 337
  year: 2015
  end-page: 346
  ident: bib2
  article-title: Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up
  publication-title: J Am Coll Cardiol
– volume: 18
  start-page: 1170
  year: 2017
  end-page: 1178
  ident: bib5
  article-title: Evaluation of coronary plaque characteristics with coronary computed tomography angiography in patients with non-obstructive coronary artery disease: a long-term follow-up study
  publication-title: Eur Heart J Cardiovasc Imaging
– start-page: 39115
  year: 2017
  ident: bib29
  article-title: Incremental prognostic value of coronary computed tomography angiography: high-risk plaque characteristics in asymptomatic patients
  publication-title: J Atheroscler Thromb
– volume: 312
  start-page: 1754
  year: 2014
  end-page: 1763
  ident: bib23
  article-title: Nonobstructive coronary artery disease and risk of myocardial infarction
  publication-title: JAMA
– volume: 135
  start-page: 2320
  year: 2017
  end-page: 2332
  ident: bib36
  article-title: Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)
  publication-title: Circulation
– volume: 22
  start-page: 459
  year: 1993
  end-page: 467
  ident: bib33
  article-title: Manifestations of coronary atherosclerosis in young trauma victims—an autopsy study
  publication-title: J Am Coll Cardiol
– volume: 50
  start-page: 319
  year: 2007
  end-page: 326
  ident: bib17
  article-title: Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes
  publication-title: J Am Coll Cardiol
– volume: 177
  start-page: 21
  year: 2017
  end-page: 23
  ident: bib35
  article-title: Statins for primary prevention: the debate is intense, but the data are weak
  publication-title: JAMA Intern Med
– volume: 93
  start-page: 172
  year: 2007
  end-page: 176
  ident: bib10
  article-title: Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
  publication-title: Heart
– volume: 10
  start-page: e004896
  year: 2017
  ident: bib34
  article-title: Predictive value of age- and sex-specific nomograms of global plaque burden on coronary computed tomography angiography for major cardiac events
  publication-title: Circ Cardiovasc Imaging
– volume: 2
  start-page: e000234
  year: 2015
  ident: bib13
  article-title: Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial
  publication-title: Open Heart
– volume: 51
  start-page: 5
  year: 1975
  end-page: 40
  ident: bib12
  article-title: A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association
  publication-title: Circulation
– volume: 3
  start-page: 144
  year: 2018
  end-page: 152
  ident: bib21
  article-title: Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial
  publication-title: JAMA Cardiol
– volume: 48
  start-page: 646
  year: 2013
  end-page: 653
  ident: bib18
  article-title: Histogram analysis of lipid-core plaques in coronary computed tomographic angiography: ex vivo validation against histology
  publication-title: Invest Radiol
– volume: 21
  start-page: 453
  year: 2014
  end-page: 466
  ident: bib27
  article-title: Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease
  publication-title: J Nucl Cardiol
– volume: 83
  start-page: 361
  year: 2000
  end-page: 366
  ident: bib22
  article-title: The pathophysiology of acute coronary syndromes
  publication-title: Heart
– volume: 113
  start-page: 30
  year: 2006
  end-page: 37
  ident: bib28
  article-title: Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA)
  publication-title: Circulation
– volume: 61
  start-page: 1041
  year: 2013
  end-page: 1051
  ident: bib19
  article-title: Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques
  publication-title: J Am Coll Cardiol
– volume: 71
  start-page: 363
  year: 2007
  end-page: 366
  ident: bib14
  article-title: Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging
  publication-title: Circ J
– volume: 379
  start-page: 924
  year: 2018
  end-page: 933
  ident: bib6
  article-title: CT coronary angiography and 5 year risk of myocardial infarction
  publication-title: N Engl J Med
– volume: 11
  start-page: 455
  year: 2017
  end-page: 461
  ident: bib20
  article-title: Coronary CT angiography features of ruptured and high-risk atherosclerotic plaques: correlation with intra-vascular ultrasound
  publication-title: J Cardiovasc Comput Tomogr
– volume: 16
  start-page: 267
  year: 2003
  end-page: 272
  ident: bib1
  article-title: Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque
  publication-title: J Interven Cardiol
– volume: 136
  start-page: 1993
  year: 2017
  end-page: 2005
  ident: bib31
  article-title: Prognostic value of coronary artery calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)
  publication-title: Circulation
– volume: 5
  start-page: 1243
  year: 2012
  end-page: 1252
  ident: bib15
  article-title: The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography
  publication-title: J Am Coll Cardiol Img
– volume: 17
  start-page: 120
  year: 2016
  end-page: 129
  ident: bib4
  article-title: Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 16
  start-page: 1545
  year: 1990
  end-page: 1549
  ident: bib24
  article-title: Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis
  publication-title: J Am Coll Cardiol
– volume: 13
  start-page: 184
  year: 2012
  ident: bib9
  article-title: Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial
  publication-title: Trials
– volume: 385
  start-page: 2383
  year: 2015
  end-page: 2391
  ident: bib7
  article-title: CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial
  publication-title: Lancet
– volume: 71
  start-page: 2511
  year: 2018
  end-page: 2522
  ident: bib25
  article-title: Coronary atherosclerotic precursors of acute coronary syndromes
  publication-title: J Am Coll Cardiol
– volume: 12
  start-page: 125
  year: 2018
  end-page: 130
  ident: bib16
  article-title: Coronary artery disease reporting and data system (CAD-RADSTM): Inter-observer agreement for assessment categories and modifiers
  publication-title: J Cardiovasc Comput Tomogr
– volume: 54
  start-page: 49
  year: 2009
  end-page: 57
  ident: bib3
  article-title: Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome
  publication-title: J Am Coll Cardiol
– volume: 136
  start-page: 2006
  year: 2017
  end-page: 2008
  ident: bib30
  article-title: Computed tomography or functional stress testing for the prediction of risk: can i have my cake and eat it?
  publication-title: Circulation
– volume: 93
  start-page: 172
  year: 2007
  ident: 10.1016/j.jacc.2018.10.066_bib10
  article-title: Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
  publication-title: Heart
  doi: 10.1136/hrt.2006.108167
– volume: 12
  start-page: 125
  year: 2018
  ident: 10.1016/j.jacc.2018.10.066_bib16
  article-title: Coronary artery disease reporting and data system (CAD-RADSTM): Inter-observer agreement for assessment categories and modifiers
  publication-title: J Cardiovasc Comput Tomogr
  doi: 10.1016/j.jcct.2017.11.014
– volume: 48
  start-page: 646
  year: 2013
  ident: 10.1016/j.jacc.2018.10.066_bib18
  article-title: Histogram analysis of lipid-core plaques in coronary computed tomographic angiography: ex vivo validation against histology
  publication-title: Invest Radiol
  doi: 10.1097/RLI.0b013e31828fdf9f
– volume: 10
  start-page: e004896
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib34
  article-title: Predictive value of age- and sex-specific nomograms of global plaque burden on coronary computed tomography angiography for major cardiac events
  publication-title: Circ Cardiovasc Imaging
  doi: 10.1161/CIRCIMAGING.116.004896
– volume: 83
  start-page: 361
  year: 2000
  ident: 10.1016/j.jacc.2018.10.066_bib22
  article-title: The pathophysiology of acute coronary syndromes
  publication-title: Heart
  doi: 10.1136/heart.83.3.361
– volume: 177
  start-page: 21
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib35
  article-title: Statins for primary prevention: the debate is intense, but the data are weak
  publication-title: JAMA Intern Med
  doi: 10.1001/jamainternmed.2016.7585
– volume: 11
  start-page: 455
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib20
  article-title: Coronary CT angiography features of ruptured and high-risk atherosclerotic plaques: correlation with intra-vascular ultrasound
  publication-title: J Cardiovasc Comput Tomogr
  doi: 10.1016/j.jcct.2017.09.001
– volume: 71
  start-page: 2511
  year: 2018
  ident: 10.1016/j.jacc.2018.10.066_bib25
  article-title: Coronary atherosclerotic precursors of acute coronary syndromes
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2018.02.079
– volume: 82
  start-page: 265
  year: 1999
  ident: 10.1016/j.jacc.2018.10.066_bib26
  article-title: Mechanisms of progression in native coronary artery disease: role of healed plaque disruption
  publication-title: Heart
  doi: 10.1136/hrt.82.3.265
– volume: 15
  start-page: 827
  year: 1990
  ident: 10.1016/j.jacc.2018.10.066_bib11
  article-title: Quantification of coronary artery calcium using ultrafast computed tomography
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(90)90282-T
– volume: 22
  start-page: 459
  year: 1993
  ident: 10.1016/j.jacc.2018.10.066_bib33
  article-title: Manifestations of coronary atherosclerosis in young trauma victims—an autopsy study
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(93)90050-B
– volume: 16
  start-page: 267
  year: 2003
  ident: 10.1016/j.jacc.2018.10.066_bib1
  article-title: Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque
  publication-title: J Interven Cardiol
  doi: 10.1034/j.1600-0854.2003.8042.x
– volume: 17
  start-page: 120
  year: 2016
  ident: 10.1016/j.jacc.2018.10.066_bib4
  article-title: Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis
  publication-title: Eur Heart J Cardiovasc Imaging
  doi: 10.1093/ehjci/jev325
– volume: 135
  start-page: 2320
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib36
  article-title: Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.116.024360
– volume: 66
  start-page: 337
  year: 2015
  ident: 10.1016/j.jacc.2018.10.066_bib2
  article-title: Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.05.069
– volume: 385
  start-page: 2383
  year: 2015
  ident: 10.1016/j.jacc.2018.10.066_bib7
  article-title: CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)60291-4
– volume: 67
  start-page: 1759
  year: 2016
  ident: 10.1016/j.jacc.2018.10.066_bib8
  article-title: Use of coronary computed tomographic angiography to guide management of patients with coronary disease
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.02.026
– volume: 13
  start-page: 184
  year: 2012
  ident: 10.1016/j.jacc.2018.10.066_bib9
  article-title: Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial
  publication-title: Trials
  doi: 10.1186/1745-6215-13-184
– volume: 2
  start-page: e000234
  year: 2015
  ident: 10.1016/j.jacc.2018.10.066_bib13
  article-title: Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial
  publication-title: Open Heart
  doi: 10.1136/openhrt-2014-000234
– volume: 379
  start-page: 924
  year: 2018
  ident: 10.1016/j.jacc.2018.10.066_bib6
  article-title: CT coronary angiography and 5 year risk of myocardial infarction
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1805971
– volume: 51
  start-page: 5
  year: 1975
  ident: 10.1016/j.jacc.2018.10.066_bib12
  article-title: A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association
  publication-title: Circulation
  doi: 10.1161/01.CIR.51.4.5
– volume: 50
  start-page: 319
  year: 2007
  ident: 10.1016/j.jacc.2018.10.066_bib17
  article-title: Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.03.044
– volume: 54
  start-page: 49
  year: 2009
  ident: 10.1016/j.jacc.2018.10.066_bib3
  article-title: Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.02.068
– volume: 61
  start-page: 1041
  year: 2013
  ident: 10.1016/j.jacc.2018.10.066_bib19
  article-title: Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.10.054
– volume: 5
  start-page: 1243
  year: 2012
  ident: 10.1016/j.jacc.2018.10.066_bib15
  article-title: The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography
  publication-title: J Am Coll Cardiol Img
  doi: 10.1016/j.jcmg.2012.03.019
– volume: 136
  start-page: 1993
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib31
  article-title: Prognostic value of coronary artery calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.117.030578
– volume: 16
  start-page: 1545
  year: 1990
  ident: 10.1016/j.jacc.2018.10.066_bib24
  article-title: Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(90)90298-4
– volume: 21
  start-page: 453
  year: 2014
  ident: 10.1016/j.jacc.2018.10.066_bib27
  article-title: Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease
  publication-title: J Nucl Cardiol
  doi: 10.1007/s12350-014-9865-9
– volume: 312
  start-page: 1754
  year: 2014
  ident: 10.1016/j.jacc.2018.10.066_bib23
  article-title: Nonobstructive coronary artery disease and risk of myocardial infarction
  publication-title: JAMA
  doi: 10.1001/jama.2014.14681
– start-page: 39115
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib29
  article-title: Incremental prognostic value of coronary computed tomography angiography: high-risk plaque characteristics in asymptomatic patients
  publication-title: J Atheroscler Thromb
– volume: 136
  start-page: 2006
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib30
  article-title: Computed tomography or functional stress testing for the prediction of risk: can i have my cake and eat it?
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.117.031178
– volume: 18
  start-page: 1170
  year: 2017
  ident: 10.1016/j.jacc.2018.10.066_bib5
  article-title: Evaluation of coronary plaque characteristics with coronary computed tomography angiography in patients with non-obstructive coronary artery disease: a long-term follow-up study
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 3
  start-page: 144
  year: 2018
  ident: 10.1016/j.jacc.2018.10.066_bib21
  article-title: Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2017.4973
– volume: 113
  start-page: 30
  year: 2006
  ident: 10.1016/j.jacc.2018.10.066_bib28
  article-title: Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA)
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.580696
– volume: 11
  start-page: 1475
  year: 2018
  ident: 10.1016/j.jacc.2018.10.066_bib32
  article-title: Effects of statins on coronary atherosclerotic plaques: The PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) Study
  publication-title: J Am Coll Cardiol Img
  doi: 10.1016/j.jcmg.2018.04.015
– volume: 71
  start-page: 363
  year: 2007
  ident: 10.1016/j.jacc.2018.10.066_bib14
  article-title: Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging
  publication-title: Circ J
  doi: 10.1253/circj.71.363
– reference: 30678760 - J Am Coll Cardiol. 2019 Jan 29;73(3):302-304. doi: 10.1016/j.jacc.2018.11.017.
SSID ssj0006819
Score 2.6833878
Snippet Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this...
AbstractBackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque....
BackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic...
Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.BACKGROUNDUnlike most...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 291
SubjectTerms Aged
Angina pectoris
Angiography
Arteriosclerosis
atherosclerotic plaque
Calcification
Calcification (ectopic)
Calcinosis - diagnostic imaging
Calcium
Cardiology
Cardiovascular
Cardiovascular disease
Clinical trials
Computed tomography
Computed Tomography Angiography
coronary angiography
Coronary artery
Coronary artery disease
Coronary Artery Disease - complications
Coronary Artery Disease - diagnostic imaging
Coronary Stenosis - etiology
Coronary vessels
Death
Family medical history
Female
Follow-Up Studies
Heart attacks
Heart diseases
Humans
Male
Medical imaging
Middle Aged
Myocardial infarction
Myocardial Infarction - etiology
Patients
Plaque, Atherosclerotic - complications
Plaque, Atherosclerotic - diagnostic imaging
Statistical analysis
Tomography
Title Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0735109718392106
https://www.clinicalkey.es/playcontent/1-s2.0-S0735109718392106
https://dx.doi.org/10.1016/j.jacc.2018.10.066
https://www.ncbi.nlm.nih.gov/pubmed/30678759
https://www.proquest.com/docview/2169226803
https://www.proquest.com/docview/2179469381
https://pubmed.ncbi.nlm.nih.gov/PMC6342893
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYoh6qXqu8GKHKl3qqwcZw4zrGNQCskSiVA3ZtrO7YIQgGR7IFLfwu_hV_GTF7qAqJST1HssfyY8XhGnvlMyBdwY1NmnQ7B-gUHJdEu1GVqQu9h2JHxpSsxOfngh5ifJPuLdLFGijEXBsMqB93f6_ROWw8ls2E1Z5dVNTsC4Uzx_rQ741kHu80T2SXxLb5P2ljI7nEPJA6Rekic6WO8zrRFGEMmdzDCq0NKfPRwemh83o-h_OtQ2ntFXg7WJP3WD_g1WXP1G_L8YLgvf0t-FwhQoK-ukcTB5-e5hh5osQrTTEcmuZL-qtpT2j3T3Dh6uGxhYVxDq_r2BkxFelQcHofzXbCCKUYgXr8jJ3u7x8U8HN5UCG0q8zbULiu5iLT10mL6pBYuSXUcoZtlBTOcx85mUeSFy7LMa6M9505KKzOjRWL4e7JeX9TuI6Ex3hl6E5nElknJfW7QweVGyFzIyLOAsHExlR0Ax_Hdi3M1RpadKWSAQgZgGTAgIF-nNpc93MaT1HzkkRoTSUH1KTgNnmyVPdbKNcPubRRTTawi9UDCApJOLVeE9J89bo0CpKZOYiZysH1lxAPyeaqGzY03Nrp2F0ukQfz_HKyqgHzo5W1aFvT1YKPlMJ0VSZwIEDh8taauTjsAccHB6cz5xn9OZ5O8gD8MswvjfIust1dL9wlMs9Zsk2c7f9h2twPvAO8-OQ8
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELYQSG0vFf1PC9SVeqvSTeLEcY4lAi0tC5VY1L25tmOLIBQQyR54mz5Ln6wz-VMXEJV6imSP5dgzHs_IM98Q8hHc2CQ0Vvlg_YKDEivrqyLRvnPw24F2hS0wOXl2xKen8ddFslgj-ZALg2GVve7vdHqrrfuWSb-bk6uynJyAcCb4ftre8SHCbm-ANcBRtA8Wu6M65qKt7oHUPpL3mTNdkNe5MohjGIrPGOLVQiXeezvdtT5vB1H-dSvtb5KnvTlJv3R__Iys2eo5eTTrH8xfkJ85IhSo6xsksfD5fqFgBpqv4jTTgUu2oD_K5oy2dZprS4-XDeyMrWlZ_f4FtiI9yY_n_nQPzGCKIYg3L8np_t48n_p9UQXfJCJrfGXTgvFAGScM5k8qbuNERQH6WYaHmrHImjQIHLdpmjqllWPMCmFEqhWPNXtF1qvLyr4hNMJHQ6cDHZsiLpjLNHq4THORcRG40CPhsJnS9IjjWPjiQg6hZecSGSCRAdgGDPDIp3HMVYe38SA1G3gkh0xS0H0SroMHR6X3jbJ1f3xrGco6koG8I2IeScaRK1L6zxm3BgGS4yRRyDMwfkXAPPJh7IbTjU82qrKXS6TBAgAZmFUeed3J27gt6OzBSctgOSuSOBIgcvhqT1WetQjinIHXmbG3_7mc9-TxdD47lIcHR9_ekSfQgzF3fpRtkfXmemm3wU5r9E57Dv8AXAQ7OA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronary+Artery+Plaque+Characteristics+Associated+With+Adverse+Outcomes+in%C2%A0the+SCOT-HEART+Study&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Williams%2C+Michelle+C.%2C+MBChB%2C+PhD&rft.au=Moss%2C+Alastair+J.%2C+MD&rft.au=Dweck%2C+Marc%2C+MBChB%2C+PhD&rft.au=Adamson%2C+Philip+D.%2C+MD%2C+PhD&rft.date=2019-01-29&rft.issn=0735-1097&rft.volume=73&rft.issue=3&rft.spage=291&rft.epage=301&rft_id=info:doi/10.1016%2Fj.jacc.2018.10.066&rft.externalDBID=ECK1-s2.0-S0735109718392106&rft.externalDocID=1_s2_0_S0735109718392106
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109718X00096%2Fcov150h.gif